Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy

Kirsten A. White, Kate Connor, Maxime Meylan, +42

Annals of Oncology

PTEN inhibits AMPK to control collective migration

Florent Péglion, Lavinia Capuana, Isabelle Perfettini, +7

Nature Communications

Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers

Ioannis Ntafoulis, Anne Kleijn, Jie Ju, +37

British Journal of Cancer

Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic Subtypes

Anne Vessières, Emie Quissac, Nolwenn Lemaire, +6

International Journal of Molecular Sciences

Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model

Mohammed Ahmed, Isaias Hernández-Verdín, Emie Quissac, +14

Pharmaceutics

Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of Oncogenic miRNAs

Chloé Maucort, Maurinne Bonnet, Jean‐Claude Ortuno, +7

Journal of Medicinal Chemistry

Comparative analysis of deeply phenotyped GBM cohorts of ‘short-term’ and ‘long-term’ survivors

Archita Biswas, Manuela Salvucci, Kate Connor, +39

Journal of Neuro-Oncology